Moleculin Biotech (MBRX) Earnings Date, Estimates & Call Transcripts → Top-Secret Government Project Revealed (From Porter & Company) (Ad) Free MBRX Stock Alerts $4.30 -0.05 (-1.15%) (As of 11:03 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 9EstimatedActual EPS (May. 10) -$2.02 Beat By $1.57 Consensus EPS (May. 10) -$3.59 Get Moleculin Biotech Earnings AlertsEnter your email address below to receive the latest news and earnings results for MBRX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueMBRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MBRX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad The Oxford ClubCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having to buy a single stock?Click here now to claim your FREE copy of Marc's AI playbook. Moleculin Biotech Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($3.59)($3.59)($3.59)Q2 20241($2.10)($2.10)($2.10)Q3 20241($1.46)($1.46)($1.46)Q4 20241($1.53)($1.53)($1.53)FY 20244($8.68)($8.68)($8.68)MBRX Earnings Date and InformationMoleculin Biotech last released its quarterly earnings data on May 10th, 2024. The reported ($2.02) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($3.59) by $1.57. Moleculin Biotech has generated $0.00 earnings per share over the last year. Earnings for Moleculin Biotech are expected to grow in the coming year, from ($8.79) to ($5.28) per share. Moleculin Biotech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 9th, 2024 based off prior year's report dates.Read More Moleculin Biotech Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/9/2024(Estimated)------- 5/10/2024Q1 2024($3.59)($2.02)+$1.57($2.02)--11/13/2023Q3 2023($3.15)($2.85)+$0.30($0.19)--8/11/2023Q2 2023($4.20)($3.00)+$1.20($0.20)--5/11/2023Q1 2023($3.75)($4.20)($0.45)($0.28)--3/22/2023Q4 2022($4.20)($3.60)+$0.60($0.24)--11/10/2022Q3 2022($4.05)($4.50)($0.45)($0.30)-- Get the Latest News and Ratings for MBRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Moleculin Biotech and its competitors with MarketBeat's FREE daily newsletter. 8/15/2022Q2 2022($3.75)($3.60)+$0.15($0.24)--5/11/2022Q1 2022($3.15)($3.60)($0.45)($0.24)--3/25/2022Q4 2021($3.15)($2.55)+$0.60($0.25)--11/11/2021Q3($3.00)($2.25)+$0.75($0.15)--8/10/2021Q2($2.8050)($2.25)+$0.5550($0.23)--5/11/2021Q1 2021($3.45)($3.00)+$0.45($0.20)--3/23/2021Q4 2020($8.70)($3.90)+$4.80---11/19/2020Q3($8.37)($5.40)+$2.97($0.06)-- 8/12/2020Q2 2020($8.10)($15.30)($7.20)$0.01-- 5/11/2020Q1 2020($9.00)($9.00)-($0.18)--3/19/2020Q4 2019($9.90)($7.20)+$2.70($0.08)--11/12/2019Q3($7.65)($8.10)($0.45)($0.09)-- 8/16/2019Q2($9.45)($2.70)+$6.75($0.15)-- Moleculin Biotech Earnings - Frequently Asked Questions When is Moleculin Biotech's earnings date? Moleculin Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 9th, 2024 based off last year's report dates. Learn more on MBRX's earnings history. Did Moleculin Biotech beat their earnings estimates last quarter? In the previous quarter, Moleculin Biotech (NASDAQ:MBRX) reported ($2.02) earnings per share (EPS) to beat the analysts' consensus estimate of ($3.59) by $1.57. Learn more on analysts' earnings estimate vs. MBRX's actual earnings. How much profit does Moleculin Biotech generate each year? Moleculin Biotech (NASDAQ:MBRX) has a recorded net income of -$29.77 million. MBRX has generated $0.00 earnings per share over the last four quarters. What is Moleculin Biotech's EPS forecast for next year? Moleculin Biotech's earnings are expected to grow from ($8.79) per share to ($5.28) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Vaccinex Earnings Results Reviva Pharmaceuticals Earnings Results Clene Earnings Results Xilio Therapeutics Earnings Results Immuneering Earnings Results Eyenovia Earnings Results HCW Biologics Earnings Results Acurx Pharmaceuticals Earnings Results Lipocine Earnings Results NRx Pharmaceuticals Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple Stock All-Time Highs: Can AI Outweigh Earnings Jitters?CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry Shifts This page (NASDAQ:MBRX) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersMoonshot Coins for the Current Crypto RunAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...The Oxford Club | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moleculin Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moleculin Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.